<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[biotech industry Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/biotech+industry.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to biotech industry]]></description>
	<s:counts start="0" returned="20" found="26" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Why Biogenerics Will Survive Genzyme's Problems]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100037/why-biogenerics-will-survive-genzymes-problems/]]></link>
		<description><![CDATA[The Food and Drug Administration rejected Genzyme's request to sell a version of its drug Myozyme made in a new factory, a decision some journalists and bloggers insist on casting as a black mark against the very notion of generic biotech drugs.    There's just one problem: These...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 22 Apr 2008 13:23:03 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+drug.html"><![CDATA[Biotech Drug]]></category>
		<category domain="http://resources.bnet.com/topic/wsj+health+blog.html"><![CDATA[WSJ Health Blog]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[BioCentury and Thomson Financial Reach Milestone With 15th Annual Future Leaders in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200803/ai_n24933213]]></link>
		<description><![CDATA[BioCentury Publications, Inc. and Thomson Financial announced today the 36 companies selected to present at Future Leaders in the Biotech Industry conference on March 27 in New York, marking the 15th year of service Future Leaders has provided to the biotech industry and its partners in the financial community. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 20 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[leader]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Venture capitalists bullish on greentech and biotech, while China and India remain hot, KPMG study says.(MARKET INTELLIGENCE)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6531/is_200802/ai_n25887329]]></link>
		<description><![CDATA[Venture capitalists will largely direct their investments to the  greentech and biotech industries in 2008, while China and India remain  hot destinations for venture funds, according to a recent survey by the  U.S. audit, tax and advisory firm KPMG LLP  Venture capitalists will largely direct their...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/venture+capital.html"><![CDATA[venture capital]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/kpmg+international.html"><![CDATA[KPMG International]]></category>
	</item>
	<item>
		<title><![CDATA[Celgene Corporation to Present at the NewsMakers in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_31/ai_n27361334]]></link>
		<description><![CDATA[SUMMIT, N.J. -- Celgene Corporation (NASDAQ: CELG) announced today that its presentation at the NewsMakers in the Biotech Industry Conference on Thursday, September 6, 2007 at 3:00 pm EDT will be webcast live and will be available in the investor relations section of the Company's website at www.celgene.com. Sol J....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 31 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="tickers">CELG</category>
	</item>
	<item>
		<title><![CDATA[Molecular Insight Pharmaceuticals, Inc. To Present At NewsMakers In The Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_29/ai_n27358006]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming Thomson Financial and BioCentury NewsMakers In The Biotech Industry Conference on September 6, 2007. During his presentation, Mr. Barlow will provide...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Tercica to Present at the BioCentury and Thomson Financial NewsMakers in the Biotech Industry Conference on September 6]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_27/ai_n27355910]]></link>
		<description><![CDATA[BRISBANE, Calif. -- Tercica, Inc. (NASDAQ:TRCA) today announced that Company management will make an investment community presentation at the BioCentury and Thomson Financial NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center in New York. Tercica's presentation will begin at 1:30 p.m. Eastern time (10:30...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 27 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Biolex Therapeutics to Present at the BioCentury and Thomson Financial "Future Leaders in the Biotech Industry" Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200703/ai_n18753541]]></link>
		<description><![CDATA[Biolex Therapeutics today announced that it will be presenting at the Future Leaders in the Biotech Industry conference hosted by BioCentury and Thomson Financial on Thursday, March 29, 2007 at the Millennium Broadway Hotel in New York City.  Biolex management will provide an update regarding recent and upcoming milestones,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 26 Mar 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Serenex Invited to Present at the BioCentury and Thomson Financial Conference -- "Future Leaders in The Biotech Industry"]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200703/ai_n18754694]]></link>
		<description><![CDATA[Serenex, Inc., an integrated oncology-focused drug discovery and development company, announced today that Dr. Richard Kent, chief executive officer, is scheduled to present at the Future Leaders in The Biotech Industry conference, hosted by BioCentury, taking place March 29th, 2007, at the Millennium Broadway Hotel in New York City. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Mar 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[GenVec to Present at BioCentury and Thomson Financial's Future Leaders in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_March_22/ai_n27190638]]></link>
		<description><![CDATA[GAITHERSBURG, M.D. -- GenVec, Inc. (Nasdaq:GNVC) today announced that Paul H. Fischer, Ph.D., President and CEO, will present a corporate overview and highlight recent developments at the 2007 Future Leaders in the Biotech Industry Conference hosted by BioCentury and Thomson Financial. Dr. Fischer's presentation will take place on Thursday, March...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Mar 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals to Present at Thomson Financial and BioCentury's: NewsMakers in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Sept_5/ai_n16703881]]></link>
		<description><![CDATA[SHORT HILLS, N.J. -- Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) announced today that Spiro Rombotis, President and Chief Executive Officer, will present an overview of the Company and its pipeline at the 13th Annual Thomson Financial and BioCentury's: NewsMakers in the Biotech Industry Conference in New York. Mr. Rombotis' presentation will...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Tercica to Present at the BioCentury and Thomson Financial NewsMakers in the Biotech Industry Conference on September 7]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Sept_1/ai_n26974272]]></link>
		<description><![CDATA[BRISBANE, Calif. -- Tercica, Inc. (NASDAQ:TRCA) today announced that Company management will make an investment community presentation at the BioCentury and Thomson Financial NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center in New York. Tercica's presentation will begin at 2:00 p.m. Eastern time (11:00...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/thomson+corp..html"><![CDATA[Thomson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TOC</category>
		<category domain="tickers">TOC</category>
	</item>
	<item>
		<title><![CDATA[Genitope Corporation to Present at Two Upcoming Investor Conferences in New York City: BioCentury's NewsMakers in the Biotech Industry and the Bear Stearns Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_August_31/ai_n26972992]]></link>
		<description><![CDATA[FREMONT, Calif. -- Genitope Corporation (Nasdaq: GTOP) today announced that it will be presenting at BioCentury's NewsMakers in the Biotech Industry Conference in New York City on September 7, 2006 and Bear Stearns Healthcare Conference in New York City on September 11, 2006.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Aug 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bear+stearns+%2526+co.+inc..html"><![CDATA[Bear Stearns & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[GENETIC ENGINEERING: CROPLIFE LAUNCHES GUIDANCE DOCUMENT FOR GM FIELD TRIALS.(genetically modified crops)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6567/is_200510/ai_n25947388]]></link>
		<description><![CDATA[The issue of field trials and ensuring that GM grains do not mix  with conventional ones is at the heart of the frequently ferocious  debate on GMOs which has consumed the EU in recent months. Back in  April, the biotech industry's credibility took a bl  The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 06 Oct 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[biotech industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/general+motors+corp..html"><![CDATA[General Motors Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/genetic+engineering.html"><![CDATA[genetic engineering]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GMGMQ</category>
		<category domain="tickers">GMGMQ</category>
	</item>
	<item>
		<title><![CDATA[ImClone Systems to Present at the 2005 NewsMakers in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_7/ai_n15372624]]></link>
		<description><![CDATA[NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) announced today that Michael J. Howerton, Chief Financial Officer, is scheduled to present at the 2005 NewsMakers in the Biotech Industry Conference in New York City on Friday, September 9, 2005, from 3:20 PM to 3:45 PM Eastern Daylight Time. Mr. Howerton...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">IMCL</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics to Present at the 12th Annual NewsMakers in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_2/ai_n15340708]]></link>
		<description><![CDATA[SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated (Nasdaq:CYTK) announced today that James H. Sabry, M.D., Ph.D., President & Chief Executive Officer, is scheduled to present a corporate update at the 12th Annual NewsMakers in the Biotech Industry Conference. The presentation is scheduled to occur on Friday, September 9th at 11:30...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, to Present "The Biomarker Gold Rush is On!" at the Third Annual Collaborations & Licensing in the Pharma & Biotech Industries Conference in London, England]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200504/ai_n13601557]]></link>
		<description><![CDATA[Health Discovery Corporation (OTC BB: HDVY) today announced that Dr. Stephen D. Barnhill, Chairman and CEO, will present "The Biomarker Gold Rush is On!" at the Third Annual Collaborations & Licensing in the Pharma & Biotech Industries Conference in London, England, on June 30, 2005. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 12 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[AVANIR Pharmaceuticals Invites Investors to the Future Leaders in the Biotech Industry Conference Webcast]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_4/ai_n13502824]]></link>
		<description><![CDATA[SAN DIEGO -- AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 12th Annual Future Leaders in the Biotech Industry Conference on April 7, 2005 in New York. President and Chief Executive Officer Gerald J. Yakatan, Ph.D. will provide a corporate update 3:50 p.m. Eastern time.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 04 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics to Present at the BioCentury Future Leaders in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_March_31/ai_n13495079]]></link>
		<description><![CDATA[SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that James H. Sabry, M.D., Ph.D., President and Chief Executive Officer is scheduled to present a corporate update at the BioCentury Future Leaders in the Biotech Industry Conference. The presentation is scheduled to occur on Thursday, April 7, 2005...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Celgene Will Present at NewsMakers in the Biotech Industry Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200409/ai_n8557652]]></link>
		<description><![CDATA[Celgene Corporation (NASDAQ: CELG) announced today that its presentation at the NewsMakers in the Biotech Industry Conference on Thursday, September 9, 2004 at 11:30 am EDT will be webcast live and will be available in the investor relations section of the Company's website at www.celgene.com.  Celgene senior management will...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 03 Sep 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="tickers">CELG</category>
	</item>
	<item>
		<title><![CDATA[Biotech Location Strategies]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=66049]]></link>
		<description><![CDATA[Biotech Hot Spots Offer Firms Large and Small a Host of Attractions. The biotech industry has grown tremendously over the past decade, with revenues increasing from $8 billion in 1992 to $34.8 billion in 2001. What's more, biotechnology is one of the most research-intensive industries in the world. The United...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 01 Sep 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/conway+data.html"><![CDATA[Conway Data]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+industry.html"><![CDATA[Biotech Industry]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
	</item>
</channel>
</rss>
